en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
6/2006
vol. 44
 
Share:
Share:
more
 
 
abstract:

Oryginal paper
Idiopathic anterior uveitis – is it a rheumatic disease?

Artur Bachta
,
Mateusz Tłustochowicz

Reumatologia 2006; 44, 6: 304–308
Online publish date: 2006/12/15
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Anterior uveitis is an acute, recurrent, sight-threatening disease that in 20% of patients leads to severe visual loss
or blindness. 60% of patients with anterior uveitis have additional manifestations of systemic disease; in 85% of them spondyloarthropathy (SpA) can be diagnosed. However,
up to 30% of patients with anterior uveitis cannot be diagnosed with any associated disease. We studied 20 patients (11 men,
9 women, mean age 34 yrs) with recurrent, non-exogenous, sight-threatening AU. Rheumatic disease was diagnosed in
9 (45%) patients; all of them were diagnosed as seronegative spondylarthropathy. 17 (85%) patients agreed for treatment with disease-modifying anti-rheumatic drugs (DMARDs). The drug
of first choice was cyclosporin A. The treatment period was
at least 11 months. We observed relapse in 4 patients during treatment. 13 patients are still in remission. On the basis
of cumulative proportion analysis we confirmed significant extension of remission period during treatment compared with mean remission period before treatment. We concluded that treatment with DMARDs in patients with anterior uveitis led
to significant extension of remission period, independently
of systemic disease diagnosis.
keywords:

autoimmune uveitis, noninfectious anterior uveitis, seronegative spondylarthropathies







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.